Table 2 Treatment effect on QOL based on EQ-5D-3 L and SF-6D in the LEVA trial
Baseline | 3 months | 1 year | ||||
|---|---|---|---|---|---|---|
QOLa | P-value | QOL change from baseline | P-value | QOL change from baseline | P-value | |
Based on EQ-5D-3 L | ||||||
Intervention group | 0.889 | +0.013 | 0.60 | +0.022 | 0.37 | |
Control group | 0.880 | -0.017 | 0.56 | -0.031 | 0.15 | |
Difference intervention-control | +0.019 | 0.48 | +0.030 | 0.43 | +0.053 | 0.10 |
Based on SF-6D | ||||||
Intervention group | 0.706 | +0.048 | <0.01 | +0.047 | <0.01 | |
Control group | 0.702 | +0.020 | 0.09 | +0.003 | 0.83 | |
Difference intervention-control | +0.004 | 0.82 | +0.028 | 0.17 | +0.044 | 0.03 |